Representative CD31, Ki-67, cleaved PARP, VEGF, and p-ERK1/2 immunohistochemical stainings for vehicle- and sorafenib-treated RCC-07-0408 and RCC-02-0908 tumour xenografts were shown in Figure 3. Here, VEGFA is linked to neoplasm.